ReviewFrontiers in human neuroscience2025
Neurophysiological approaches for managing pain in multiple sclerosis: a mini review.
Review in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Hypothesis of Myelinodegeneration as an Initial Risk of Neuropathic Pain.Neuroscience bulletin · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic pain is a prevalent yet often under-recognized symptom among individuals with multiple sclerosis (MS), affecting 29-86% of the population. This condition can significantly impact the individuals' functionality, including their capacity to engage in professional activities. The pathophysiology underlying this condition remains intricate and not fully elucidated, and inadequate responses to pharmacological interventions or adverse effects can hinder its management. In light of these observations, there is an urgent need to identify new therapeutic interventions. Non-invasive brain stimulation (NIBS) techniques hold promise for addressing MS-related pain. This mini-review aims to analyze the findings from studies using NIBS techniques, such as transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS), to assess their analgesic potential in people with MS. Seven relevant reports are available. Five of these studies used tDCS, one utilized a transcranial random noise stimulation (tDCS variant), and one compared rTMS with transcranial theta burst stimulation (rTMS variant). The results indicate the potential benefits of NIBS for pain management in MS. However, the study's limitations, including the scarcity of data, small sample size, the limited number of sessions, sham design, and brief follow-up, are also noted and discussed. Finally, directions for future research are suggested.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.